COVID-19 Testing as a Contributory Cause of Delayed Treatment of a Pyogenic Liver Abscess

Am Surg. 2023 Apr;89(4):1202-1205. doi: 10.1177/0003134820983201. Epub 2020 Dec 30.
No abstract available

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • COVID-19 Testing
  • COVID-19* / complications
  • Humans
  • Liver Abscess, Pyogenic* / diagnosis
  • Liver Abscess, Pyogenic* / therapy
  • Time-to-Treatment

Substances

  • Anti-Bacterial Agents